Correlation Between Vitamin D Status and Bone Mineral Density in Patients With Hemophilia
NCT ID: NCT01090206
Last Updated: 2016-04-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2010-03-31
2015-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of High-Dose Vitamin D on Bone Density in Osteogenesis Imperfecta
NCT01713231
Does Vitamin D Deficiency Associated With Hypercoagulability & Increased Thrombin Generation?
NCT01799655
Relationships Between Vitamin D and Orthopedic Trauma
NCT04564625
The Effect of Vitamin D Supplementation on Calcium Excretion in Thalassemia: a Dose Response Study
NCT01323608
A Study of 25-hydroxy Vitamin d Levels in Non-itching Hemodialysis Patients
NCT01548716
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hemophilia, Vitamin D deficiency
1. Hemophilia, Rickets - Vitamin D per endocrine consult
2. Hemophilia, Vitamin D deficient - Vitamin D 2000 units daily plus calcium
3. Hemophilia, Normal Vitamin D - no intervention - observation only
Vitamin D and calcium
Doses will be based on Vitamin D levels
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vitamin D and calcium
Doses will be based on Vitamin D levels
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ages 2-21 years
Exclusion Criteria
2 Years
21 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CSL Behring
INDUSTRY
Virginia Commonwealth University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gita V Massey, M.D.
Role: PRINCIPAL_INVESTIGATOR
Virginia Commonwealth University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Virginia Commonwealth University Health System
Richmond, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PT 104212
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.